Global /France /Healthcare /Medical Devices /ALCAR

Carmat S.A.

ALCAR

• EPA: ALCAR • Delayed

0.0990EUR 0%

0.1150 USD

As of 5 June 2026, Carmat S.A. has a market cap of $7.14M USD, ranking #42962 globally and #530 in France. It ranks #3797 in the Healthcare sector, and #798 in the Medical Devices industry.

Global Rank

42962

Country Rank

530

Sector Rank

3797

Industry Rank

798

Key Stats

Market Cap

$7.14MUSD

6.15M EUR

Enterprise Value

$68.81MUSD

59.25M EUR

Revenue (TTM)

$8.53MUSD

7.34M EUR

EBITDA (TTM)

-$54.86MUSD

-47.23M EUR

Net Income (TTM)

-$59.7MUSD

-51.4M EUR

PS Ratio

0.8

PB Ratio

-0.2

Company Profile

Country (HQ)

France

Sector

Healthcare

Industry

Medical Devices

CEO

Stephane Piat open_in_new

Employees

153

Founded

2008

Website

carmatsa.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-	-25%	-74%	-10%	-91%	-89%	-99%	-100%

News

Markets

Exchange	Ticker	Price	Quotes
Euronext Paris (EPA) MIC: XPAR PRIMARY	ALCAR Carmat ISIN: FR0010907956 Shares Out.: Shares Outstanding: 64.233M¹ Shares Float: 52.019M² TV: TradingView: EURONEXT: ALCAR SA: Stock Analysis: EPA: ALCAR YF: Yahoo Finance: ALCAR.PA GF: Google Finance: EPA: ALCAR BA: Barron's: ALCAR MS: Morningstar: XPAR: ALCAR	0.0990 EUR	TV: TradingView: EURONEXT: ALCAR SA: Stock Analysis: EPA: ALCAR YF: Yahoo Finance: ALCAR.PA GF: Google Finance: EPA: ALCAR BA: Barron's: ALCAR MS: Morningstar: XPAR: ALCAR

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Carmat S.A.

Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.

Similar Companies

Industry: Medical Devices (France)

Name	Market Cap (USD) diff.	PE	Country
EssilorLuxottica Société anonyme EPA: EL	$97.94B 84.32B EUR 1M%	36.7	France
Sartorius Stedim Biotech S.A. EPA: DIM	$17.72B 15.26B EUR 248K%	56.8	France
bioMérieux S.A. EPA: BIM	$9.56B 8.23B EUR 134K%	20.9	France
Eurobio Scientific Société anonyme EPA: ALERS	$268.97M 231.57M EUR 4K%	47.3	France
Carvolix S.A. EPA: AFME	$196.8M 169.44M EUR 3K%	-	France
Guerbet S.A. EPA: GBT	$174.36M 150.12M EUR 2K%	-	France

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 2M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 2M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 2M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 2M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 2M%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 1M%	22.2	Ireland

chevron_leftBack